EGR1 and cardiovascular disorder: Additionally, researchers have used catalytic and non-catalytic nucleic acid methods such as DNAzymes, microRNAs, and oligonucleotide decoys in animal models in conjunction with Egr-1-deficient mice to obtain novel insights into the regulatory role played by Egr-1 in cardiovascular diseases.